Loading clinical trials...
Loading clinical trials...
To look for the replication of HHV6 by PCR in the skin, in these patients with haemopathies presenting an exanthema. This will make it possible to evaluate the prevalence of the positivity of this PCR in the skin. Then the investigator can investigate whether there is an association between the positivity of HHV6 PCR in the blood and / or skin and the viral etiology of the exanthema. If this association exists, it will make it possible to improve the diagnosis in the context of the exanthema and thus to improve the therapeutic management of these patients.
Age
All ages
Sex
ALL
Healthy Volunteers
No
CHU Amiens Picardie
Amiens, Picardie, France
Start Date
December 13, 2016
Primary Completion Date
June 13, 2017
Completion Date
June 13, 2017
Last Updated
April 6, 2017
45
ESTIMATED participants
Measurement of the prevalence of the positivity of cutaneous HHV6 quantitative PCR in the cohort studied.
OTHER
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
NCT06399029
NCT07112846
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions